Sanofi SA
SNY
查看詳細走勢圖
48.680USD
-0.180-0.37%
收盤 12/12, 16:00（美東）報價延遲15分鐘
118.50B總市值
11.78本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-0.37%
5天
-1.72%
1月
-6.64%
6月
-1.99%
今年開始到現在
+0.93%
1年
+4.02%
查看詳細走勢圖
TradingKey Sanofi SA股票評分
單位: USD 更新時間: 2025-12-12操作建議
Sanofi SA當前公司基本面數據相對健康，增長潛力很大。當前估值合理，在藥品行業排名69/159位。機構持股佔比非常高，近一個月多位分析師給出公司評級為買入。最高目標價61.88。中期看，股價處於平穩狀態。近一個月，市場表現較差，但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Sanofi SA評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
9
分析師
買入
評級
61.882
目標均價
+27.75%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
Sanofi SA亮點
亮點風險
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
高分紅
公司屬於高分紅公司，最新股息支付率171.67%
穩定分紅
公司5年內持續分紅，最新股息支付率171.67%
估值低估
公司最新PE估值11.78，處於3年歷史低位
機構減倉
最新機構持股251.34M股，環比減少9.80%
理查德·皮茲納持倉
明星投資者理查德·皮茲納持倉，最新持倉6.67K股
Sanofi SA新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Sanofi SA簡介
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
公司代碼SNY
公司Sanofi SA
CEOHudson (Paul)
網址https://www.sanofi.com/
常見問題
Sanofi SA(SNY)的當前股價是多少？
Sanofi SA(SNY)的當前股價是 48.680。
Sanofi SA 的股票代碼是什麼？
Sanofi SA的股票代碼是SNY。
Sanofi SA股票的52週最高點是多少？
Sanofi SA股票的52週最高點是60.115。
Sanofi SA股票的52週最低點是多少？
Sanofi SA股票的52週最低點是44.617。
Sanofi SA的市值是多少？
Sanofi SA的市值是118.50B。
Sanofi SA的淨利潤是多少？
Sanofi SA的淨利潤為6.01B。
現在Sanofi SA(SNY)的股票是買入、持有還是賣出？
根據分析師評級，Sanofi SA(SNY)的總體評級為買入，目標價格為61.882。
Sanofi SA(SNY)股票的每股收益（EPS TTM）是多少
Sanofi SA(SNY)股票的每股收益（EPS TTM）是4.133。
相關品種
+1.83%
+0.76%
-0.31%
-0.51%
+0.15%
+1.33%
+0.11%
-0.23%
-2.28%
+0.23%
+1.37%
+2.40%
-0.23%
-0.16%
-0.73%
-0.74%
0.00%
-1.30%
-3.65%
